Durvalumab plus enfortumab vedotin reduced the risk of an event or death compared with radical cystectomy alone.
|Articles|February 15, 2021
Pharmacy Times: Week of February 15 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Susan Swindells, MD, a professor in the Department of Internal Medicine and Medical Director in the Specialty Care Clinic at the University of Nebraska Medical Center, on a once-monthly, long-acting regimen for HIV recently approved by the FDA and how it will impact care for patients with HIV.
- A new episode of Pharmacy Focus that discusses performance measures in pharmacy and leadership techniques for pharmacists with Jesse McCullough.
- An article that provides an overview on the importance of sleep in infant children. Studies have shown that sleep benefits infants’ memories and general cognitive and emotional development.
Advertisement
Related to this article
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Category 1 placement for belantamab mafodotin plus bortezomib and dexamethasone puts guideline support ahead of the FDA label.
No new vouchers have been awarded since former FDA Commissioner Marty Makary left the agency in May, although HHS maintains the pilot is ongoing.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
Glucose Monitoring: Timing Makes Every Reading Count
5